CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Activate Immunotherapy

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 29, 2010

Acquired by Viopro on Oct 26, 2015

Timeline

1990s

Jun 1, 1997
Activate Immunotherapy— Founded

2010s

Oct 26, 2015
Viopro— Acquired By

Drugs by trial phase (1 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

belagenpumatucel-l

Indications

Studied for

Recent trials (4)

NCT01279798Lead sponsorN/AOct 29, 2010
NCT00676507Lead sponsorPhase 3Jul 1, 2008
NCT01058785Study directorPhase 2Mar 1, 2003
NCT01058785Lead sponsorPhase 2Mar 1, 2003

Details

Founded: San Diego, CA, US Jun 1, 1997
Last known activity: Oct 29, 2010

Notes

formerly NovaRx Corporation